Clinical Trial Update: Therapeutic Control of Aspirin-Exacerbated Respiratory Disease With Ifetroban [Phase 2]

View source ↗

Summary

Phase 2 trial investigating Ifetroban for aspirin-exacerbated respiratory disease (AERD) shows completed status with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspirin-exacerbated Respiratory Disease
• Aspirin-sensitive Asthma with Nasal Polyps
• Asthma
• Nasal Polyps

Drugs mentioned

• Ifetroban (Ifetroban)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Nasal Polyps, Asthma, Aspirin-Induced | Phase 2 | Status: COMPLETED | Results posted: 2023-07-14